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Public perceptions on data sharing: key insights from the 
UK and the USA
Data science and artificial intelligence (AI) have the 
potential to transform the delivery of health care. Health 
care as a sector, with all of the longitudinal data it holds 
on patients across their lifetimes, is positioned to take 
advantage of what data science and AI have to offer. The 
current COVID-19 pandemic has shown the benefits of 
sharing data globally to permit a data-driven response 
through rapid data collection, analysis, modelling, and 
timely reporting.
Despite its obvious advantages, data sharing 
is a controversial subject, with researchers and members 
of the public justifiably concerned about how and why 
health data are shared. The most common concern 
is privacy; even when data are (pseudo-)anonymised, 
there remains a risk that a malicious hacker could, using 
only a few datapoints, re-identify individuals. For many, 
it is often unclear whether the risks of data sharing 
outweigh the benefits.
A series of surveys over recent years indicate that the 
public holds a range of views about data sharing.1,2 Over 
the past few years, there have been several important 
data breaches and cyberattacks.3 This has resulted in 
patients and the public questioning the safety of their 
data, including the prospect or risk of their health data 
being shared with unauthorised third parties.4
We surveyed people across the UK and the USA to 
examine public attitude towards data sharing, data 
access, and the use of AI in health care. These two 
countries were chosen as comparators as both are high-
income countries that have had substantial national 
investments in health information technology (IT) 
with established track records of using data to support 
health-care planning, delivery, and research. The 
UK and USA, however, have sharply contrasting models 
of health-care delivery, making it interesting to observe 
if these differences affect public attitudes.
Data from 3194 respondents (aged >18 years) across 
the UK (n=2080) and the USA (n=1114) were used 
from an online 2018 YouGov survey that we developed 
(appendix p 1). YouGov is a widely used research plat-
form that develops nationally representative surveys 
through active sampling, ensuring a nationally represen-
tative pool; the final responses are statistically weighted 
(by the UK Office for National Statistics and the 
US Census Bureau) to the national profile of each country 
for adults aged 18 years or older.
Although most respondents were aware of electronic 
health records (EHRs), their use was not widespread 
in either country, especially in the UK (14·3% vs 44·5% 
in the USA). Women and older patients were slightly 
more likely to report access to their EHRs, suggesting 
EHR access might be associated with relative health-
service use (figure).
Willingness to share anonymised personal health infor-
mation varied across receiving bodies (figure). The more 
commercial the purpose of the receiving institution 
(eg, for an insurance or tech company), the less often 
respondents were willing to share their anonymised 
personal health information in both the UK and the USA. 
Older respondents (≥35 years) in both countries were 
generally less likely to trust any organisation with their 
anonymised personal health information than younger 
respondents (<35 years).
Despite low numbers of access, many UK 
(59·0%, 95% CI 56·9–61·1) and US (70·1%, 67·4–72·8) 
respon dents regarded access to their medical records 
as useful (appendix pp 2, 4). 
In both countries, more respondents were happy 
to receive advice from their doctor or nurse without 
assistance from AI than with it (58·2% [95% CI 56·1–60·3] 
vs 54·8% [52·7–56·9] in the UK and 51·8% [48·8–51·2] 
vs 38·2% [35·4–64·6] in the USA; appendix pp 3, 5). 
By contrast with US respondents, a small majority 
of UK respondents were happy to receive care from 
AI software as long as it was there to support a doctor or 
nurse (appendix pp 3, 5). Younger respondents (≤44 years) 
were more willing to receive advice from independent 
AI than older respondents (>44 years) in both the USA 
and the UK (appendix pp 3, 5).
The ambition both in the USA and the UK is to enable 
patient access to EHRs; however, our results suggest 
access and use is not widespread. This might partly be 
explained by relative health-care consumption rather than 
a lack of information or support. Yet, there are also many 
barriers to accessing health records, such as poor usability 
and interoperability, language barriers, overall mistrust in 
See Online for appendix
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the health system, or concerns about insurance eligibility. 
A previous study in the USA found that ethnic minority 
and lower income patients adopt EHRs less often than 
white and higher income patients,5 suggesting further 
research is needed to tackle inequity in digital health. 
Patient involvement in the design of digital applications 
might be imperative to appropriately respond to rapidly 
evolving expectations of digital services—especially for 
Figure: Citizens’ awareness of access to their EHRs and willingness to share their anonymised personal health information
95% CIs for all estimates are provided in the appendix (pp 4–5). EHR=electronic health record.
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those who have grown up with technology.6 Young adults 
now extensively use digital resources to access health 
information, digital health tools, and peer support7 and 
this presents an important opportunity for health-care 
provision amid the COVID-19 crisis. 
A key finding from this work was the importance of 
trust. Although the majority of respondents in both 
countries were willing to share their data with their 
doctor, it is worrying that in the USA more than a 
third are not. The fact that distrust in the USA, which 
has a largely privatised system, was higher than in the 
UK, which has a socialised single-payer system, might 
indicate that patients are concerned that data might 
not be protected from commercial end-use.8 This 
is supported by our findings comparing willingness 
to share across public (eg, government, research 
institution) and commercial end-users (eg, insurance 
and tech companies). When institutions are likely to 
use data for commercial purposes, respondents were 
less willing to share their data, espe cially in the case of 
tech organisations. Our findings indicate a sharp shift 
in public opinion compared with a Wellcome Trust 
survey in 2016 in which half of UK respondents were 
willing to share data with commercial organisations.9 
This suggests that the growing commodi fication 
of patient data, and recent tech scandals such as 
Cambridge Analytica in 2018, have increased public 
awareness of the risks and consequences of sharing 
data with commercial and tech industries.10 This 
pattern is also reflected in a 2018 survey done by 
RockHealth in the USA, showing a substantial decline 
in the number of individuals willing to share their 
health data with tech companies.1
The data analysed here were obtained through 
a YouGov survey, which results in some limitations. No 
ethnic demographic data were obtained, the survey was 
conducted in English, and all participants needed to 
have IT access—all factors that highlight potential biases 
of the survey data.
Despite the benefits of big data and technology 
in health care, our findings suggest that the rapid 
development of novel technologies has been received 
with concern. Growing commodification of patient 
data has increased awareness of the risks involved in 
data sharing. There is a need for public standards that 
secure regulation and transparency of data use and 
sharing and support patient understanding of how data 
are used and for what purposes.4
The implications of our findings amid the COVID-19 
pandemic remain unclear. While the urgency of data 
science and AI is becoming increasingly evident as 
the COVID-19 outbreak grows globally, the crisis also 
imposes new risks to public privacy and data security. 
Further work needs to be done to understand how this 
catastrophic public health emergency will affect public 
views on data sharing.
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